What is the recommended treatment for buttock cellulitis in a healthy adult?

Treatment of Buttock Cellulitis in Healthy Adults

For a healthy adult with buttock cellulitis, start with oral antibiotics targeting β-hemolytic streptococci as first-line therapy, specifically a β-lactam such as cephalexin 500 mg four times daily for 5-10 days. 1

Initial Assessment: Purulent vs. Nonpurulent

The critical first step is determining whether the cellulitis is purulent (with drainage/exudate or drainable abscess) or nonpurulent (simple erythema, warmth, swelling without purulent features).

For Nonpurulent Buttock Cellulitis (Most Common)

• First-line treatment: β-lactam antibiotic targeting streptococci 1, 2

  • Cephalexin 500 mg PO four times daily, OR
  • Dicloxacillin 500 mg PO four times daily
  • Duration: 5-10 days (5 days is sufficient if improving) 1, 3

• When to add MRSA coverage: Only if the patient fails to respond to β-lactam therapy within 48-72 hours, or if systemic toxicity is present 1, 2

For Purulent Buttock Cellulitis

If there is purulent drainage or an associated abscess:

1. Incision and drainage is the primary treatment if an abscess is present 1

2. Empirical MRSA coverage is recommended pending cultures 1:

   • Clindamycin 300-450 mg PO three times daily (covers both streptococci and MRSA) 1, OR
   • TMP-SMX 1-2 double-strength tablets twice daily PLUS amoxicillin 500 mg three times daily (for streptococcal coverage) 1
   • Alternative: Doxycycline 100 mg twice daily plus amoxicillin 1

When to Escalate Care

Hospitalize and use IV antibiotics if any of the following are present 1:

• Systemic signs of infection (fever, tachycardia, hypotension)
• Rapid progression despite oral therapy
• Immunosuppression or significant comorbidities
• Concern for deeper infection (necrotizing fasciitis, abscess)

For hospitalized patients, use IV vancomycin 15-20 mg/kg every 8-12 hours as first-line MRSA coverage 1, 2

Important Clinical Pearls

The buttock location matters: While not explicitly an "area difficult to drain" like the face or genitalia, buttock cellulitis warrants careful assessment for underlying abscess (pilonidal cyst, perirectal abscess, or psoas abscess presenting as buttock cellulitis) 4. If atypical features are present or the patient fails standard therapy, imaging should be considered.

Duration controversy: The evidence supports 5 days of treatment as sufficient if clinical improvement is occurring 1, 5, 3. Extension to 10 days should only occur if improvement is inadequate at day 5. The 2014 IDSA guidelines explicitly state 5 days is the recommended duration 5.

Oral vs. IV route: For patients who can tolerate oral medications and lack systemic toxicity, oral antibiotics are as effective as IV therapy 6. The 2011 IDSA guidelines note that oral macrolides were more effective than IV penicillin in some studies 6, reinforcing that route alone does not determine efficacy.

Common Pitfalls to Avoid

1. Over-treating with MRSA coverage: In nonpurulent cellulitis without risk factors, empirical MRSA coverage is unnecessary and contributes to antibiotic resistance 1, 7. The majority of simple cellulitis is streptococcal.

2. Treating too long: Extending antibiotics beyond 5 days when the patient is improving has no proven benefit and increases adverse effects 3.

3. Missing a deeper abscess: Buttock cellulitis that fails to improve warrants imaging to exclude psoas abscess, perirectal abscess, or other deep-seated infection 4.

4. Unnecessary cultures: Blood cultures and tissue cultures are not routinely needed for uncomplicated cellulitis in immunocompetent patients 5. Reserve cultures for severe infection, systemic signs, or treatment failure.